September 4, 2014 — Healthcare professionals will be able to access information about the latest and most complete oncology guidelines available at the point of care following an agreement between EBSCO Health and the National Comprehensive Cancer Network (NCCN). Information from NCCN will be summarized along with other evidence and guidelines in the content available from the clinical reference tool DynaMed.

NCCN, a not-for-profit alliance of 25 of the world's leading cancer centers, is dedicated to improving the quality, effectiveness and efficiency of cancer care. Through the leadership and expertise of clinical professionals at NCCN member institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the healthcare delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians and other healthcare decision-makers.

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) document evidence-based, consensus-driven management to ensure all patients receive preventive, diagnostic, treatment and supportive services that are most likely to lead to optimal outcomes. DynaMed will be able to use these guidelines as a reference to augment the existing evidence and guidelines that it considers when updating oncology topics. The DynaMed guidelines will include citations of the NCCN Content and will show the NCCN Categories of Evidence and Consensus.

DynaMed founder and vice president for evidence-based medicine research and development, quality and standards, Brian Alper, M.D., says the addition of the NCCN Guidelines as a clinical reference will enhance the currency of DynaMed’s oncology content. “Oncology is a field that changes very quickly and being able to utilize the NCCN Guidelines is a way to ensure the oncology content in DynaMed is the most current and comprehensive,” he said.

Several studies have shown DynaMed provides the most useful information to healthcare professionals at the point of care. DynaMed ranked highest among 10 online clinical resources in a study in the Journal of Clinical Epidemiology and twice was rated highest in its category by healthcare providers in a report on clinical decision support resources by KLAS.

For more information: www.health.ebsco.com/products/dynamed/clinical-decision-support

Related Content

News | Clinical Decision Support

April 22, 2021 — Change Healthcare unveiled InterQual 2021, the latest edition of the company’s flagship clinical ...

Time April 22, 2021
arrow
News | Clinical Decision Support

April 2, 2021 — Elsevier, a global leader in research publishing and information analytics, announced a partnership with ...

Time April 02, 2021
arrow
News | Clinical Decision Support

June 16, 2020 — Philips and The University of Texas MD Anderson Cancer Center announced a collaboration to provide ...

Time June 16, 2020
arrow
News | Clinical Decision Support

March 13, 2020 — IBM Watson Health and EBSCO Information Services (EBSCO) announced a strategic collaboration aimed ...

Time March 13, 2020
arrow
News | Clinical Decision Support

December 26, 2019 — Effective Jan. 1, 2020, new regulations under the Centers for Medicare & Medicaid Services (CMS) ...

Time December 26, 2019
arrow
Videos | Radiology Business

Association for Medical Imaging Management (AHRA) President Chris Tomlinson, CRA, FAHRA, and President-elect Jacqui Rose ...

Time August 02, 2019
arrow
News | Clinical Decision Support

On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School of Medicine has been designated a qualified provider-led entity (qPLE). This allows Johns Hopkins to develop criteria that meet the requirements of the federal Protecting Access to Medicare Act (PAMA) of 2014 when ordering diagnostic imaging tests such as computed tomography (CT) scans, magnetic resonance imaging (MRI) scans and nuclear imaging in the emergency department and ambulatory settings.

Time July 18, 2019
arrow
News | Digital Pathology

July 16, 2019 — Computational pathology company Paige announced the publication of an article in Nature Medicine ...

Time July 16, 2019
arrow
News | Ultrasound Women's Health

Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Time July 11, 2019
arrow
News | Interventional Radiology

Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. When completed, this acquisition, in combination with the recent acquisitions of Endocare and Alicon, will expand Varian's portfolio of multidisciplinary integrated cancer care solutions.

Time July 03, 2019
arrow
Subscribe Now